The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

A multi-task learning framework, DEMENTIA, has been developed by Prof. Li Hai and his team at the Hefei Institutes of ...

As Alzheimer’s disease is the most common form of dementia — affecting an estimated 6.7 million Americans — it’s not surprising that people who experience memory loss may suspect AD.

Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical trial has demonstrated the potential of focused ultrasound to safely ...

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.